Knee Replacement Clinical Trials

Clinical trials related to Knee Replacement Procedure

Suzetrigine for Treatment and Reduction of Intense Discomfort After knEe Replacement PAIN

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

This is a prospective, randomized study. The purpose of this study is to evaluate if the addition of Suzetrigine, a new pain medication, to well established peri-operative pain regimen used for total knee replacement surgery will effect pain control. 1. Does Suzetrigine given pre-operatively decrease the total opioid consumed after total knee replacement surgery? 2. Dose Suzetrigine given pre-operatively decrease the visual analog pain scale pain scores after total knee replacement surgery? Study participants will be randomly assigned to receive either Suzetrigine medication or placebo medication.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

⁃ To be eligible to participate in this study, an individual must meet all of the following criteria:

• Adults 18-85 years old

• Scheduled to undergo total knee replacement surgery

• All genders

Locations
United States
New York
Mount Sinai West
RECRUITING
New York
Contact Information
Primary
Michael Lazar, MD
michael.lazar@mountsinai.org
212-523-2500
Backup
Himani Bhatt, DO
himani.bhatt@mountsinai.org
212-523-2500
Time Frame
Start Date: 2026-04
Estimated Completion Date: 2027-02-23
Participants
Target number of participants: 235
Treatments
Experimental: Suzetrigine
Participants will receive 100 mg loading dose (2 pills) of Suzetrigine medication pre-operatively, then 50 mg dose (1 pill) of Suzetrigine every 12 hours for total of 5 days.
Placebo_comparator: Placebo
Participants will receive 2 pills that are made to look like the Suzetrigine pill to take per-operatively, then 1 pill every 12 hours for a total of 5 days.
Related Therapeutic Areas
Sponsors
Leads: Icahn School of Medicine at Mount Sinai

This content was sourced from clinicaltrials.gov